July 24, 2026

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

A panel of ASCO experts voted to approve ASCO’s first guideline on ctDNA testing in patients with solid tumors or lymphoma on November 18, 2025.1 The guideline addresses four overarching clinical ques...

The ASCO Post

July 24, 2026

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

A panel of ASCO experts voted to approve ASCO’s first guideline on ctDNA testing in patients with solid tumors or lymphoma on November 18, 2025.1 The guideline addresses four overarching clinical ques...

The ASCO Post

July 21, 2026

AMP Recognizes NCI Pathologist With Award for Excellence in Molecular Diagnostics

Her research has revealed the molecular underpinnings of T-cell, B-cell, and natural killer–cell lymphomas, and her insights into Epstein–Barr virus–associated disorders, Castleman disease, and immune...

The ASCO Post

June 25, 2026

Multi-Cancer Early Detection Test Evaluated in Real-World Asian Cohort

A large real-world study conducted across six Asian countries suggests that a blood-based multi-cancer early detection test may accurately identify multiple cancer types in routine clinical practice, ...

The ASCO Post

June 12, 2026

Machine Learning Model May Improve Accuracy of Liquid Biopsy Results

Investigators developed a machine learning model called plasmaCHORD that uses characteristics of the DNA fragments to estimate whether a mutation found in a liquid biopsy originates from the tumor or ...

The ASCO Post

June 11, 2026

Head and Neck Cancer: HPV-DeepSeek May Identify Earlier Signs of Postoperative Recurrence

Researchers clinically validated a sensitive blood test as a whole-genome sequencing assay for detecting circulating tumor human papillomavirus (HPV) DNA in patients with HPV-associated head and neck ...

The ASCO Post

June 11, 2026

Head and Neck Cancer: HPV-DeepSeek May Identify Earlier Signs of Postoperative Recurrence

Researchers clinically validated a sensitive blood test as a whole-genome sequencing assay for detecting circulating tumor human papillomavirus (HPV) DNA in patients with HPV-associated head and neck ...

The ASCO Post

June 10, 2026

Early Study Finds Intralesional PD-1 Blockade ‘Promising’ for Oral Cancer Prevention

Intralesional nivolumab reduced the size of precancerous lesions and preserved quality of life in patients with oral epithelial dysplasia, according to results from a first-in-human phase I dose-escal...

The ASCO Post

June 10, 2026

Early Study Finds Intralesional PD-1 Blockade ‘Promising’ for Oral Cancer Prevention

Intralesional nivolumab reduced the size of precancerous lesions and preserved quality of life in patients with oral epithelial dysplasia, according to results from a first-in-human phase I dose-escal...

The ASCO Post

April 29, 2026

AI-Powered, Next-Generation Sequencing Blood-Based Assay Evaluated for Detection of Post-HCT Relapse in AML and MDS

Monitoring for relapse with an artificial intelligence (AI)-powered peripheral blood-based tool called AlloHeme demonstrated greater sensitivity in predicting relapse after hematopoietic cell transpla...

The ASCO Post